Results 291 to 300 of about 4,976,171 (334)

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Clinical phenotype and molecular genetic analysis of 24 cases of Beckwith-Wiedemann syndrome. [PDF]

open access: yesTransl Pediatr
Wu Z   +9 more
europepmc   +1 more source

Genetic Analysis Reveals a Protective Effect of Sphingomyelin on Cholelithiasis. [PDF]

open access: yesGenes (Basel)
Mao K   +13 more
europepmc   +1 more source

Distribution and population genetic analysis of lymnaeid snails in Aomori prefecture, Japan. [PDF]

open access: yesJ Vet Med Sci
Kamiharako Y   +11 more
europepmc   +1 more source

Genetic analysis of congenital hemimelia in buffaloes from Southern Italy

open access: green, 2013
Simona Tafuri   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy